Academic Bibliography

Search 200 years of publications by Ghent University researchers.

prof. dr. Jimmy Van den Eynden

Faculty of Medicine and Health Sciences > Department of Human Structure and Repair

ORCID iD: 0000-0003-0002-5614

Add to list
- Journal Article
- A2
- open access
MHC class II genotypes are independent predictors of anti-PD1 immunotherapy response in melanoma

Arne Claeys (UGent) and Jimmy Van den Eynden (UGent)

(2024) COMMUNICATIONS MEDICINE. 4(1).
Add to list
Effects of hyperthermia on cisplatin tissue penetration and gene expression in peritoneal metastases : results from a randomized trial in ovarian cancer

Jesse Demuytere (UGent) , Charlotte Carlier, Tom Van Helden (UGent) , Joke Belza (UGent) , Frank Vanhaecke (UGent) , Feifan Xie, An Vermeulen (UGent) , Joseph Weerts, Jürgen Thomale, Hannelore Denys (UGent) , et al.

(2024) BRITISH JOURNAL OF SURGERY. 111(4).
Add to list
- Journal Article
- A2
- open access
Preclinical exploration of the DNA damage response pathway using the interactive neuroblastoma cell line explorer CLEAN

Jonatan Linus Gabre (UGent) , Peter Merseburger (UGent) , Arne Claeys (UGent) , Joachim Siaw (UGent) , Sarah-Lee Bekaert (UGent) , Franki Speleman (UGent) , Bengt Hallberg, Ruth H Palmer and Jimmy Van den Eynden (UGent)

(2024) NAR CANCER. 6(1).
Add to list
- Journal Article
- A1
- open access
ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition

Marcus Borenäs, Ganesh Umapathy, Dan E. Lind, Wei-Yun Lai, Jikui Guan, Joel Johansson, Eva Jennische, Alexander Schmidt, Yeshwant Kurhe, Jonatan Linus Gabre (UGent) , et al.

(2024) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 121(1).
Add to list
- Miscellaneous
- open access
A systematic analysis of immune escape signals in the primary and metastatic tumor genome

Jimmy Van den Eynden (UGent)

(2023) NATURE GENETICS. 55. p.728-729
Add to list
- Journal Article
- A1
- open access
Benchmark of tools for in silico prediction of MHC class I and class II genotypes from NGS data

Arne Claeys (UGent) , Peter Merseburger (UGent) , Jasper Staut (UGent) , Kathleen Marchal (UGent) and Jimmy Van den Eynden (UGent)

(2023) BMC GENOMICS. 24.
Add to list
- Journal Article
- A1
- open access
Quantification of neoantigen-mediated immunoediting in cancer evolution : letter

Arne Claeys (UGent) and Jimmy Van den Eynden (UGent)

(2023) CANCER RESEARCH. 83(6). p.971-972
Add to list
- Journal Article
- A1
- open access
ALK fusion NSCLC oncogenes promote survival and inhibit NK cell responses via SERPINB4 expression

Tzu-Po Chuang, Wei-Yun Lai, Jonatan Linus Gabre (UGent) , Dan E. Lind, Ganesh Umapathy, Abdulmalik A. Bokhari, Bengt Bergman, Linnea Kristenson, Fredrik B. Thorén, Anh Le, et al.

(2023) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 120(8).
Add to list
- Journal Article
- A1
- open access
Novel human-derived EML4-ALK fusion cell lines identify ribonucleotide reductase RRM2 as a target of activated ALK in NSCLC

A.A. Bokhari, W-Y. Lai, A.T. Le, J.L. Gabre, T-P. Chuang, S. Fransson, B. Bergman, A. Djos, N. Chen, T. Martinsson, et al.

(2022) LUNG CANCER. 171. p.103-114
Add to list
- Miscellaneous
- open access
Benchmark of tools for in silico prediction of MHC class I and class II genotypes from NGS data

Arne Claeys (UGent) , Jasper Staut (UGent) , Peter Merseburger (UGent) , Kathleen Marchal (UGent) and Jimmy Van den Eynden (UGent)

(2022)

1
2
3
4
5

Next →